London, UK and Redwood City, CA (PRWEB) July 12, 2011
Medicsight PLC, an industry leader in the development of Computer Aided Detection (CAD) and medical image analysis software, has entered into an agreement with Ziosoft, Inc., the pioneer in supercomputing advanced visualization and functional analytics. The agreement includes the integration of Medicsight’s ColonCAD™ API software and Ziosoft’s Ziostation™ technology as well as distribution of both technologies by Ziosoft in the U.S. One of the first U.S. sites to use the combined Medicsight and Ziosoft technologies will be the University of Wisconsin School of Medicine and Public Health (UWH) in Madison.
“The partnership between Ziosoft and Medicsight should make a compelling match for CT colonography interpretation,” said Perry J. Pickhardt, professor of Radiology at UHW. “CTC will definitely benefit from the pairing of these companies which are two recognized leaders in the advanced visualization field.”
Medicsight received U.S. regulatory clearance for clinical use of its technology in May. Medicsight’s ColonCAD is designed to assist radiologists during their review of CT colonography (CTC – also known as “Virtual Colonoscopy”) images by automatically highlighting potential colorectal polyps (possible precursors to colorectal cancer) on the CT image. The regulatory clearance was supported by a large clinical trial involving 15 radiologist readers who each reviewed 112 patient CT colonography cases. The clinical trial results demonstrated that, when assisted by ColonCAD, radiologists’ accuracy for detecting polyps of all sizes was significantly improved compared with unassisted reading.
“Having recently received U.S. regulatory clearance for our ColonCAD software, we are now entering this important market with strategic partnerships,” said Allan Rowley, CEO for
Medicsight. “Ziosoft’s supercomputing technology provides a powerful alliance with our own state-of-the-art software. Both companies are committed to enabling more confident diagnoses with technology that has passed the scrutiny of regulatory bodies.”
Ziosoft holds numerous clearances for a variety of applications for its supercomputing visualization and functional analytics technology. Medicsight and Ziosoft have been partnering in Europe prior to the U.S. clearance of ColonCAD software.
“Both of our companies provide highly accurate and reproducible image visualization and functional analytics software to aid clinicians in diagnoses and treatment planning,” said Rob Royea, president and COO for Ziosoft. “We look forward to bringing our collective technologies to radiologists and other healthcare providers in support of excellence in patient care.”
About Medicsight PLC
Medicsight plc is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. Medicsight’s ColonCAD™ software uses an advanced CAD algorithm to analyze CT scans of the colon and automatically highlight suspicious areas that may be indicators of disease. CAD may highlight areas overlooked by the reviewing radiologist, such as small lesions or regions that are hidden from view behind folds in the colon. ColonCAD can be seamlessly integrated with advanced 3D visualization platforms of industry leading imaging equipment partners. The integrated systems provide sophisticated image viewing capabilities, including 3D reconstructed image data, with the added advantage of demonstrating automatic CAD findings to assist clinical end-users in the detection and analysis of disease. For further information, visit http://www.medicsight.com.
About Ziosoft, Inc.
Founded in 1998, Ziosoft, Inc. is a recognized leader in functional imaging visualization software to benefit clinicians, patients and healthcare specialists. The company’s supercomputing, 3D-4D advanced visualization software provides a wide array of diagnostic tools at any chosen location. With more than 2,000 systems installed worldwide, the Ziostation system from Ziosoft offers state-of-the-art technology to produce superb 3D-4D image quality, helping clinicians to make faster and more confident diagnoses. Ziosoft is a privately held company headquartered in Redwood City, Calif., with locations in Amsterdam, The Netherlands and Tokyo, Japan. For further information, visit http://www.ziosoftinc.com.
# # #